LOX Enzyme May Serve as Scleroderma Biomarker, Therapeutic Target
The molecule lysyl oxidase (LOX) plays key roles in promoting skin and lung scarring in scleroderma and may serve as a potential biomarker and therapeutic target for the disease, a study suggests. The study, “Lysyl Oxidase…